Vatalanib is a small molecule protein kinase inhibitor that inhibits angiogenesis. It is used in combination with first- and second-line chemotherapy for the treatment of metastatic colorectal cancer and non-small cell lung cancer. Reference standards of Vatalanib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
1-Chloro-4-(4-pyridinylmethyl)phthalazine
Catalogue No.:PA 22 0801000
CAS :
Molecular Formula : C14H10ClN3
Molecular Weight : 255.71
Vatalanib
Catalogue No.:PA 22 0800000
Molecular Formula : C20H15ClN4
Molecular Weight : 346.82
4-(4-Pyridylmethyl)-1(2H)-phthalazinone
Catalogue No.:PA 22 0801001
Molecular Formula : C14H11N3O
Molecular Weight : 237.26
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....